Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Severe Toxicity of Targeted Therapies in Elderly Patients With Cancer

NCT02751827 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT02751827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02751827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Severe Toxicity of Targeted Therapies in Elderly Patients With Cancer
Lead sponsor
Institut Bergonié
Phase
Observational
Overall status
Completed
Start date
February 2, 2016
Completion date
November 19, 2019
Enrollment
312 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer